Effect of dolutegravir-based versus efavirenz-based antiretroviral therapy on excessive weight gain in adult treatment-naïve HIV patients at Matsanjeni health center, Eswatini: a retrospective cohort study
Abstract Background There is limited data on dolutegravir (DTG)-associated weight gain from settings with a dual burden of HIV and overnutrition. Methods In Eswatini (at Matsanjeni), among 156 and 160 adult patients on DTG-based and EFV-based antiretroviral therapy (ART), respectively, we studied ex...
Main Authors: | Didier M. Mukuna, Tom Decroo, Clara M. Nyapokoto |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | AIDS Research and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12981-023-00591-3 |
Similar Items
-
Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir
by: Supphachoke Khemla, et al.
Published: (2023-04-01) -
Comparative Safety and Changes in Immunologic and Virologic Parameters of Dolutegravir versus Efavirenz-Based Antiretroviral Therapies Among HIV Patients: A Retrospective Cohort Study
by: Ayal MA, et al.
Published: (2023-04-01) -
Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
by: Chang Huang, et al.
Published: (2023-03-01) -
Weight gain on dolutegravir: Association is not the same as causation
by: Gary Maartens, et al.
Published: (2023-05-01) -
Outcomes of severely ill patients with AIDS treated with efavirenz or dolutegravir: a multicenter, observational study
by: Carlos Brites, et al.
Published: (2024-02-01)